Straits Times Index
3,291.35 +25.40 (+0.78%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,967.21 +429.40 (+2.32%) FTSE 100
8,424.80 +43.45 (+0.52%) Bitcoin USD
63,233.79 +1,717.08 (+2.79%) CMC Crypto 200
1,354.48 -3.53 (-0.26%)
Bionano Genomics, Inc. (BNGO)
After hours:
| Previous close | 0.9200 |
| Open | 0.9500 |
| Bid | 0.9459 x 1400 |
| Ask | 0.9848 x 400 |
| Day's range | 0.9132 - 1.0099 |
| 52-week range | 0.7100 - 8.2000 |
| Volume | |
| Avg. volume | 1,433,046 |
| Market cap | 65.687M |
| Beta (5Y monthly) | 2.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.8100 |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.67 |
Insider MonkeyBionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2024 Earnings Call Transcript May 8, 2024 Bionano Genomics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Bionano First Quarter 2024 Earnings Conference Call. Today’s conference is being […]
GlobeNewswireBionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced significant upgrades to its suite of computational tools for comprehensive cancer analysis. These advancements to the company’s VIA™ software solution enhance the detection and interpretation of aneusomies, and improve the analysis, visualization, interpretation, and reporting of data types including optical genome mapping (OGM), next generation sequencing, and microarray, for comprehensive assessme
- Thomson Reuters StreetEvents
Q1 2024 Bionano Genomics Inc Earnings Call
Q1 2024 Bionano Genomics Inc Earnings Call
